From a genetic point of view, a correlation has been found between an insertion-deletion variant, derived from TNFSF13B, which encodes BAFF, and the higher risk for MS, SLE and possibly RA 33. The gene discussed is TNFSF13B; the disease is myeloid sarcoma.